beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens.

Vassilakopoulos, T P; Nadali, G; Angelopoulou, M K; Dimopoulou, M N; Siakantaris, M P; Kontopidou, F N; Karkantaris, C; Kokoris, S I; Dimitriadou, E M; Calpadaki, C; Sarantopoulos, A; Galani, Z; Sachanas, S; Kyrtsonis, M C; Tsaftaridis, P; Variamis, E; Panayotidis, P; Pizzolo, G; Sarris, A H; Pangalis, G A

Vassilakopoulos, T P; Nadali, G; Angelopoulou, M K; Dimopoulou, M N; Siakantaris, M P; Kontopidou, F N; Karkantaris, C; Kokoris, S I; Dimitriadou, E M; Calpadaki, C; Sarantopoulos, A; Galani, Z; Sachanas, S; Kyrtsonis, M C; Tsaftaridis, P; Variamis, E; Panayotidis, P; Pizzolo, G; Sarris, A H; Pangalis, G A.

Afiliación

Vassilakopoulos TP; Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, "Laikon" General Hospital, Athens, Greece.

J BUON ; 10(1): 59-69, 2005.

Article en En | MEDLINE | ID: mdl-17335133

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J BUON Asunto de la revista: NEOPLASIAS Año: 2005 Tipo del documento: Article País de afiliación: Grecia

Buscar en Google

Imprimir

XML

PubMed Links